Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 2 010.1 INR 0.98% Market Closed
Market Cap: 152.8B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+68%
Revenue
Forecast
+12%
Operating Income
Forecast
+13%
Net Income
Forecast
+46%

Wall Street
Price Targets

CAPLIPOINT Price Targets Summary
Caplin Point Laboratories Ltd

Wall Street analysts forecast CAPLIPOINT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPLIPOINT is 2 499 INR with a low forecast of 2 424 INR and a high forecast of 2 625 INR.

CAPLIPOINT Lowest Forecast
Wall Street Target
2 424 INR
21% Upside
CAPLIPOINT Average Forecast
Wall Street Target
2 499 INR
24% Upside
CAPLIPOINT Highest Forecast
Wall Street Target
2 625 INR
31% Upside
Lowest
Price Target
2 424 INR
21% Upside
Average
Price Target
2 499 INR
24% Upside
Highest
Price Target
2 625 INR
31% Upside
Caplin Point Laboratories Ltd Competitors:
Price Targets
600085
Beijing Tongrentang Co Ltd
32% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
52% Upside
C
214370
Caregen Co Ltd
58% Upside
300725
PharmaBlock Sciences Nanjing Inc
13% Upside
600085
Beijing Tongrentang Co Ltd
32% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
52% Upside
C
214370
Caregen Co Ltd
58% Upside
300725
PharmaBlock Sciences Nanjing Inc
13% Upside
O
ORNBV
Orion Oyj
7% Upside
ZTS
Zoetis Inc
27% Upside
AUROPHARMA
Aurobindo Pharma Ltd
30% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Caplin Point Laboratories Ltd

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's revenue is 23%. The projected CAGR for the next 3 years is 16%.

23%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Caplin Point Laboratories Ltd

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's operating income is 24%. The projected CAGR for the next 3 years is 23%.

24%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Caplin Point Laboratories Ltd

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's net income is 25%. The projected CAGR for the next 3 years is 17%.

25%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
CAPLIPOINT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAPLIPOINT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAPLIPOINT stock valuation using valuation multiples.
Wall Street Estimates
CAPLIPOINT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAPLIPOINT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPLIPOINT's stock price target?
Price Target
2 499 INR

According to Wall Street analysts, the average 1-year price target for CAPLIPOINT is 2 499 INR with a low forecast of 2 424 INR and a high forecast of 2 625 INR.

What is Caplin Point Laboratories Ltd's Revenue forecast?
Projected CAGR
16%

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's revenue is 23%. The projected CAGR for the next 3 years is 16%.

What is Caplin Point Laboratories Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's operating income is 24%. The projected CAGR for the next 3 years is 23%.

What is Caplin Point Laboratories Ltd's Net Income forecast?
Projected CAGR
17%

For the last 7 years the compound annual growth rate for Caplin Point Laboratories Ltd's net income is 25%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.